Remdesivir class action lawsuit

Posted on 10/1/23 at 10:19 am

Posted by Kjnstkmn

Vermilion Parish

Member since Aug 2020

15811 posts

Posted on 10/1/23 at 10:19 am

https://www.zerohedge.com/medical/class-action-lawsuit-filed-against-remdesivir-manufacturer-over-alleged-deceptive-practices

quote:
The company that manufactures remdesivir, used across the United States to treat COVID-19, has been hit with a class-action lawsuit over allegations it deceptively promoted the drug without disclosing possible side effects.

quote:
The suit says that Gilead's press releases and statements to consumers and investigators from Gilead show "a pattern of downplaying or omitting altogether the clinical dangers experienced by patients from remdesivir use, instead emphasizing its supposed benefits, safety, and efficacy." For example, a website for the drug, also known as veklury, makes no mention of kidney problems. A handout given to patients also does not mention the issues.

quote:
"It's a terrible drug. The nonprofit has thousands of members who have the hospital records, and you can see there's a big difference in the creatinine levels and the blood levels, kidney readings after they get the remdesivir," Bradford Geyer, an attorney with Former Feds Group who is representing the plaintiffs, told The Epoch Times.

quote:
Plaintiffs are seeking class status, which would enable two groups of people to join the suit. They are people who received remdesivir while hospitalized with COVID-19 and suffered serious injuries as a result, and people whose loved ones died after receiving remdesivir after being hospitalized with COVID-19.

quote:
Animal studies found indications that remdesivir injured the kidney. The U.S. trial found kidney injuries among remdesivir recipients, including in three patients who were forced to stop taking the drug. Other studies, as well as post-approval data, have also raised safety and effectiveness concerns. Researchers reviewing reports to VigiBase, a World Health Organization database, for instance, found reports of kidney injuries after remdesivir were far higher than reports of kidney injuries after other COVID-19 treatments. Before receiving remdesivir, American patients are instructed (pdf) by the FDA to disclose all of their medical conditions, including kidney problems. Gilead, while promoting remdesivir, needed to disclose the risk of kidney injuries, according to the new suit. By not doing so, the company allegedly violated California laws against using deceptive practices and making untrue or misleading statements.